Grape King Bio Ltd
TWSE:1707.TW
151 (TWD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,632.988 | 10,391.231 | 9,798.246 | 9,168.195 | 9,239.07 | 9,183.321 | 9,388.128 | 9,185.021 | 7,247.855 | 6,282.859 | 5,652.413 | 4,611.719 | 3,771.021 | 3,282.274 | 2,821.859 | 2,112.457 | 1,702.107 | 1,489.681 |
| Cost of Revenue
| 2,099.45 | 1,909.186 | 1,942.319 | 1,631.457 | 1,673.182 | 1,854.057 | 1,523.444 | 1,265.989 | 862.714 | 721.624 | 657.393 | 583.533 | 513.948 | 521.047 | 477.512 | 1,302.101 | 1,029.144 | 915.38 |
| Gross Profit
| 8,533.538 | 8,482.045 | 7,855.927 | 7,536.738 | 7,565.888 | 7,329.264 | 7,864.684 | 7,919.032 | 6,385.141 | 5,561.235 | 4,995.02 | 4,028.186 | 3,257.073 | 2,761.227 | 2,344.347 | 810.356 | 672.963 | 574.301 |
| Gross Profit Ratio
| 0.803 | 0.816 | 0.802 | 0.822 | 0.819 | 0.798 | 0.838 | 0.862 | 0.881 | 0.885 | 0.884 | 0.873 | 0.864 | 0.841 | 0.831 | 0.384 | 0.395 | 0.386 |
| Reseach & Development Expenses
| 289.134 | 289.884 | 292.228 | 252.857 | 190.091 | 184.569 | 159.663 | 114.032 | 98.681 | 84.256 | 91.965 | 77.654 | 85.206 | 66.913 | 60.869 | 52.15 | 45.303 | 40.487 |
| General & Administrative Expenses
| 701.717 | 639.492 | 600.976 | 554.312 | 535.543 | 520.292 | 467.511 | 567.321 | 429.136 | 461.01 | 354.139 | 536.811 | 411.869 | 410.855 | 330.806 | 259.996 | 171.996 | 154.097 |
| Selling & Marketing Expenses
| 5,045.611 | 4,999.836 | 4,650.569 | 4,424.84 | 4,505.253 | 4,274.566 | 4,983.215 | 5,003.657 | 4,044.908 | 3,416.177 | 3,206.99 | 2,447.355 | 1,989.449 | 1,629.425 | 1,416.136 | 144.682 | 144.144 | 138.237 |
| SG&A
| 5,519.77 | 5,639.328 | 5,251.545 | 4,979.152 | 5,040.796 | 4,794.858 | 5,450.726 | 5,570.978 | 4,474.044 | 3,877.187 | 3,561.129 | 2,984.166 | 2,401.318 | 2,040.28 | 1,746.942 | 404.678 | 316.14 | 292.334 |
| Other Expenses
| 2.476 | 107.763 | 98.816 | -0.053 | 123.544 | 83.331 | 168.754 | 110.184 | 93.324 | 89.512 | 85.485 | 49.6 | 39.665 | 31.819 | 59.98 | 30.152 | 4.24 | 16.145 |
| Operating Expenses
| 6,039.349 | 5,929.212 | 5,543.773 | 5,231.956 | 5,230.887 | 4,979.427 | 5,610.389 | 5,685.01 | 4,572.725 | 3,961.443 | 3,653.094 | 3,061.82 | 2,486.524 | 2,107.193 | 1,807.811 | 456.828 | 361.443 | 332.821 |
| Operating Income
| 2,496.665 | 2,691.341 | 2,419.487 | 2,392.531 | 2,457.796 | 2,349.837 | 2,254.295 | 2,234.022 | 1,812.416 | 1,599.792 | 1,341.926 | 966.366 | 770.549 | 654.034 | 536.536 | 353.528 | 311.52 | 241.48 |
| Operating Income Ratio
| 0.235 | 0.259 | 0.247 | 0.261 | 0.266 | 0.256 | 0.24 | 0.243 | 0.25 | 0.255 | 0.237 | 0.21 | 0.204 | 0.199 | 0.19 | 0.167 | 0.183 | 0.162 |
| Total Other Income Expenses Net
| 163.955 | 128.15 | 103.322 | 64.66 | 95.121 | 76.827 | 151.175 | 78.477 | 70.188 | 89.426 | 97.35 | 47.086 | 45.062 | 39.416 | 75.615 | -25.33 | 47.673 | 36.388 |
| Income Before Tax
| 2,660.62 | 2,687.878 | 2,414.906 | 2,378.19 | 2,440.106 | 2,426.664 | 2,405.47 | 2,312.499 | 1,882.604 | 1,689.218 | 1,427.279 | 1,030.823 | 815.611 | 693.45 | 612.151 | 328.198 | 359.193 | 277.868 |
| Income Before Tax Ratio
| 0.25 | 0.259 | 0.246 | 0.259 | 0.264 | 0.264 | 0.256 | 0.252 | 0.26 | 0.269 | 0.253 | 0.224 | 0.216 | 0.211 | 0.217 | 0.155 | 0.211 | 0.187 |
| Income Tax Expense
| 519.109 | 518.191 | 466.917 | 483.095 | 501.54 | 536.592 | 470.738 | 425.579 | 335.72 | 302.705 | 245.85 | 184.4 | 156.924 | 129.599 | 133.123 | 85.394 | 104.386 | 67.292 |
| Net Income
| 1,452.728 | 2,169.687 | 1,947.989 | 1,895.095 | 1,938.566 | 1,295.394 | 1,351.941 | 1,296.769 | 1,051.652 | 942.483 | 835.762 | 618.902 | 473.062 | 427.7 | 379.341 | 164.522 | 180.871 | 150.422 |
| Net Income Ratio
| 0.137 | 0.209 | 0.199 | 0.207 | 0.21 | 0.141 | 0.144 | 0.141 | 0.145 | 0.15 | 0.148 | 0.134 | 0.125 | 0.13 | 0.134 | 0.078 | 0.106 | 0.101 |
| EPS
| 9.81 | 14.65 | 13.2 | 13.92 | 14.27 | 9.57 | 10.03 | 9.82 | 8.07 | 7.24 | 6.42 | 4.67 | 3.63 | 3.28 | 2.91 | 1.26 | 1.39 | 1.16 |
| EPS Diluted
| 9.74 | 14.56 | 13.13 | 13.84 | 14.19 | 9.49 | 9.93 | 9.57 | 7.94 | 7.2 | 6.39 | 4.67 | 3.63 | 3.28 | 2.91 | 1.26 | 1.39 | 1.16 |
| EBITDA
| 3,095.244 | 3,140.979 | 2,846.94 | 2,797.005 | 2,767.574 | 2,696.932 | 2,647.721 | 2,553.502 | 2,056.05 | 1,816.222 | 1,550.149 | 1,131.684 | 917.13 | 785.394 | 677.365 | 404.99 | 434.213 | 346.922 |
| EBITDA Ratio
| 0.291 | 0.302 | 0.291 | 0.306 | 0.301 | 0.295 | 0.282 | 0.278 | 0.284 | 0.289 | 0.274 | 0.247 | 0.247 | 0.238 | 0.23 | 0.238 | 0.248 | 0.225 |